Mon, Sep 1, 2014, 7:34 PM EDT - U.S. Markets closed for Labor Day


% | $
Quotes you view appear here for quick access.

Trius Therapeutics, Inc. (TSRX) Message Board

  • tigrdog3 tigrdog3 Mar 13, 2013 9:39 AM Flag

    Piper Jaffray

    March 13, 2013
    07:00 EDT TSRX Trius Therapeutics should be bought ahead of data, says Piper Jaffray
    Piper Jaffray recommends buying shares of Trius Therapeutics ahead of the ESTABLISH-2 study data later this month. The firm expects positive data to drive Trius shares higher and views the company as a potential acquisition candidate. Piper keeps an Overweight rating on the stock with an $11 price target.

13.630.00(0.00%)Sep 11 4:00 PMEDT

Trending Tickers

Trending Tickers features significant U.S. stocks showing the most dramatic increase in user interest in Yahoo Finance in the previous hour over historic norms. The list is limited to those equities which trade at least 100,000 shares on an average day and have a market cap of more than $300 million.
Criteo SA
NasdaqGSFri, Aug 29, 2014 4:00 PM EDT
Yahoo! Inc.
NasdaqGSFri, Aug 29, 2014 4:00 PM EDT